JP7353980B2 - 高含量の生体接着物質を有する電界紡糸繊維を調製する方法 - Google Patents

高含量の生体接着物質を有する電界紡糸繊維を調製する方法 Download PDF

Info

Publication number
JP7353980B2
JP7353980B2 JP2019560457A JP2019560457A JP7353980B2 JP 7353980 B2 JP7353980 B2 JP 7353980B2 JP 2019560457 A JP2019560457 A JP 2019560457A JP 2019560457 A JP2019560457 A JP 2019560457A JP 7353980 B2 JP7353980 B2 JP 7353980B2
Authority
JP
Japan
Prior art keywords
eudragit
bioadhesive
fibers
fiber
copolymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019560457A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020506307A5 (enExample
JP2020506307A (ja
Inventor
イェンス ハンセン，
Original Assignee
アフリックス セラピューティクス アー／エス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アフリックス セラピューティクス アー／エス filed Critical アフリックス セラピューティクス アー／エス
Publication of JP2020506307A publication Critical patent/JP2020506307A/ja
Publication of JP2020506307A5 publication Critical patent/JP2020506307A5/ja
Application granted granted Critical
Publication of JP7353980B2 publication Critical patent/JP7353980B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/02—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D01F6/16—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from polymers of unsaturated carboxylic acids or unsaturated organic esters, e.g. polyacrylic esters, polyvinyl acetate
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/02—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D01F6/26—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from other polymers
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/58—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
    • D01F6/62—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters
    • D01F6/625—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters derived from hydroxy-carboxylic acids, e.g. lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/14—Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
    • C08L39/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
    • C08L39/06—Homopolymers or copolymers of N-vinyl-pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Textile Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
  • Materials For Medical Uses (AREA)
  • Nonwoven Fabrics (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Artificial Filaments (AREA)
JP2019560457A 2017-01-23 2018-01-22 高含量の生体接着物質を有する電界紡糸繊維を調製する方法 Active JP7353980B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201770043 2017-01-23
DKPA201770043 2017-01-23
PCT/DK2018/050010 WO2018133910A1 (en) 2017-01-23 2018-01-22 Method for preparing electrospun fibers with a high content of a bioadhesive substance

Publications (3)

Publication Number Publication Date
JP2020506307A JP2020506307A (ja) 2020-02-27
JP2020506307A5 JP2020506307A5 (enExample) 2021-03-04
JP7353980B2 true JP7353980B2 (ja) 2023-10-02

Family

ID=58536695

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019560457A Active JP7353980B2 (ja) 2017-01-23 2018-01-22 高含量の生体接着物質を有する電界紡糸繊維を調製する方法

Country Status (14)

Country Link
US (1) US11045430B2 (enExample)
EP (1) EP3570822B1 (enExample)
JP (1) JP7353980B2 (enExample)
KR (1) KR102595001B1 (enExample)
CN (1) CN110290783A (enExample)
AU (1) AU2018209592B2 (enExample)
BR (1) BR112019014732A2 (enExample)
CA (1) CA3050026A1 (enExample)
DK (1) DK3570822T3 (enExample)
ES (1) ES2874787T3 (enExample)
IL (1) IL268185B2 (enExample)
MX (1) MX387268B (enExample)
RU (1) RU2019126497A (enExample)
WO (1) WO2018133910A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2950821C (en) * 2014-06-10 2024-02-06 Dermtreat Aps Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
ES2887977T3 (es) 2017-01-23 2021-12-29 Afyx Therapeutics As Método para la fabricación de un producto de dos capas a base de fibras electrohiladas
JP2022552832A (ja) 2019-10-08 2022-12-20 アフリックス セラピューティクス アー／エス タンパク質の送達のための組成物
ES2876401B2 (es) * 2020-05-11 2024-04-05 Bioinicia S L Parches auto-adhesivos de fibras para la liberación controlada de bioactivos
JP2024542227A (ja) 2021-11-23 2024-11-13 アフリックス デベロップメント アー／エス 粘膜パッチおよびその使用方法
KR20240073700A (ko) 2022-11-18 2024-05-27 한국생산기술연구원 다공성 폴리 유산 미세섬유 및 이의 제조방법
WO2025051337A1 (en) 2023-09-06 2025-03-13 Afyx Development A/S Compositions and methods for treating and preventing oral cancer
KR20250066118A (ko) 2023-11-06 2025-05-13 한국생산기술연구원 두가지 기능성 물질이 담지된 다공성 셀룰로오스 아세테이트 섬유 구조체 및 이의 제조방법

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009041117A (ja) 2007-08-06 2009-02-26 Nisshinbo Ind Inc 多糖類ナノファイバー
JP2013544259A (ja) 2010-11-26 2013-12-12 ユニバーシティ・オブ・ジ・ウィトウォーターズランド・ヨハネスブルク 医薬投与形態
WO2015186101A1 (en) 2014-06-05 2015-12-10 University Of The Witwatersrand, Johannesburg Wound dressing
WO2015189212A1 (en) 2014-06-10 2015-12-17 Dermtreat Aps Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
JP2016536305A (ja) 2013-10-25 2016-11-24 コンティプロ ビオテック スポレチノスト エス ルチェニム オメゼニム ヒアルロン酸をベースとする化粧品組成物，その調製法及び使用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2134635Y (zh) 1992-08-18 1993-05-26 许竞新 具有连续响声的印刷鞭炮
DE4337152A1 (de) 1993-10-30 1995-05-04 Merck Patent Gmbh Verfahren zur Herstellung von wäßrigen Chitosan-Lösungen und -Gelen
US6753454B1 (en) 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor
JP2003521493A (ja) 2000-01-28 2003-07-15 スミスクライン・ビーチャム・コーポレイション 電気紡糸された医薬組成物
WO2002076425A2 (en) 2001-03-22 2002-10-03 Battelle (Memorial Institute) Manufacturing dissolvable dosage forms
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US7309498B2 (en) 2001-10-10 2007-12-18 Belenkaya Bronislava G Biodegradable absorbents and methods of preparation
US20030017208A1 (en) 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
TW200410714A (en) 2002-08-07 2004-07-01 Smithkline Beecham Corp Electrospun amorphous pharmaceutical compositions
AU2003265446A1 (en) 2002-08-13 2004-02-25 Medtronic, Inc. Active agent delivery system including a hydrophilic polymer, medical device, and method
KR100564366B1 (ko) 2003-11-19 2006-04-07 재단법인서울대학교산학협력재단 나노 섬유형 부직포를 이용한 조직 재생용 차폐막 및 그의 제조 방법
JP4526851B2 (ja) 2004-03-31 2010-08-18 明彦 谷岡 多糖類のナノスケールの繊維および成形体
EP1796822A4 (en) 2004-10-06 2008-09-17 Res Foundation Suny INTENSE FLOW FILTRATION MEDIA WITH LOW ENCRYPTION
US7390760B1 (en) 2004-11-02 2008-06-24 Kimberly-Clark Worldwide, Inc. Composite nanofiber materials and methods for making same
WO2006106514A2 (en) 2005-04-06 2006-10-12 Nicast Ltd. Electrospun dosage form and method of producing the same
US20100190254A1 (en) 2006-12-05 2010-07-29 Nanyang Technological University Three-dimensional porous hybrid scaffold and manufacture thereof
JP5600005B2 (ja) 2007-09-05 2014-10-01 太陽化学株式会社 水溶性電界紡糸シート
EP2271301A4 (en) 2008-03-27 2014-07-02 Agigma Inc METHOD AND COMPOSITIONS FOR THE DELIVERY OF FUNDS
US8361492B2 (en) 2008-04-29 2013-01-29 Ocugenics, LLC Drug delivery system and methods of use
WO2010099292A2 (en) 2009-02-25 2010-09-02 North Carolina State University Biodegradable drug or other active delivery system
US20110111012A1 (en) 2009-11-12 2011-05-12 Hemcon Medical Technologies, Inc. Nanomaterial wound dressing assembly
CN102251317B (zh) * 2011-05-18 2013-01-16 东华大学 一种药物释放可控的电纺纤维的制备方法
US20130295143A1 (en) 2012-05-02 2013-11-07 Massachusetts Institute Of Technology Electroprocessing of active pharmaceutical ingredients
WO2014066297A1 (en) 2012-10-22 2014-05-01 North Carolina State University Nonwoven fiber materials
US9393216B2 (en) 2012-11-06 2016-07-19 University Of Washington Through Its Center For Commercialization Vaginal matrices: nanofibers for contraception and prevention of HIV infection
EP2810645B1 (en) 2013-06-06 2017-05-24 A. Sezai Sarac New Drug Delivery System
EP2813212A1 (en) 2013-06-10 2014-12-17 Zentiva, a.s. Drug formulation using API in nanofibers
CA2935237A1 (en) * 2014-01-15 2015-07-23 University Of Guelph Compositions and methods to encapsulate and control release of volatile organic compounds for increasing shelf-life of perishable products
US20160166959A1 (en) * 2014-12-12 2016-06-16 The Board Of Trustees Of The Leland Stanford Junior University Air filter for high-efficiency pm2.5 capture
MX391778B (es) 2015-11-19 2025-03-21 Dermtreat Aps Composición farmacéutica que comprende fibras obtenidas electrohidrodinámicamente y que tiene tiempo de residencia mejorado en el sitio de aplicación.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009041117A (ja) 2007-08-06 2009-02-26 Nisshinbo Ind Inc 多糖類ナノファイバー
JP2013544259A (ja) 2010-11-26 2013-12-12 ユニバーシティ・オブ・ジ・ウィトウォーターズランド・ヨハネスブルク 医薬投与形態
JP2016536305A (ja) 2013-10-25 2016-11-24 コンティプロ ビオテック スポレチノスト エス ルチェニム オメゼニム ヒアルロン酸をベースとする化粧品組成物，その調製法及び使用
WO2015186101A1 (en) 2014-06-05 2015-12-10 University Of The Witwatersrand, Johannesburg Wound dressing
WO2015189212A1 (en) 2014-06-10 2015-12-17 Dermtreat Aps Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa

Also Published As

Publication number Publication date
MX2019008155A (es) 2019-11-07
AU2018209592A1 (en) 2019-07-25
US11045430B2 (en) 2021-06-29
DK3570822T3 (da) 2021-07-26
ES2874787T3 (es) 2021-11-05
CA3050026A1 (en) 2018-07-26
KR102595001B1 (ko) 2023-10-26
RU2019126497A3 (enExample) 2021-05-26
NZ755185A (en) 2025-06-27
CN110290783A (zh) 2019-09-27
IL268185B2 (en) 2024-01-01
BR112019014732A2 (pt) 2020-03-10
IL268185A (en) 2019-09-26
US20190254986A1 (en) 2019-08-22
EP3570822B1 (en) 2021-05-05
RU2019126497A (ru) 2021-02-24
AU2018209592B2 (en) 2024-03-21
WO2018133910A1 (en) 2018-07-26
KR20190126306A (ko) 2019-11-11
JP2020506307A (ja) 2020-02-27
IL268185B1 (en) 2023-09-01
MX387268B (es) 2025-03-18
EP3570822A1 (en) 2019-11-27

Similar Documents

Publication Publication Date Title
JP7353980B2 (ja) 高含量の生体接着物質を有する電界紡糸繊維を調製する方法
Nyamweya Applications of polymer blends in drug delivery
JP2020022787A5 (enExample)
RU2695217C2 (ru) Композиции, включающие электрогидродинамически полученные волокна, для нанесения заданных доз активного вещества на кожу или слизистую оболочку
RU2019129082A (ru) Фармацевтическая композиция, содержащая электрогидродинамически полученные волокна, композиция, имеющая улучшенное время удержания в месте применения
KR102592782B1 (ko) 전기방사 섬유에 기반한 2층 제품의 제조 방법
JP6634706B2 (ja) 口腔内付着フィルム製剤
CN103402504A (zh) 包含西地那非游离碱的膜制剂及其生产方法
CN114845700A (zh) Otf的可溶性背衬层
US12280153B2 (en) Enteric hard capsule
HK40014713A (en) Method for preparing electrospun fibers with a high content of a bioadhesive substance
EP4277632B1 (de) Orale dünnfilme
HK40015030A (en) Method for fabrication of a two-layered product based on electrospun fibres
JP2024022777A (ja) 粒子分散用ゲル、粒子分散ゲルおよび粒子分散用ゲルの製造方法
CN119654368A (zh) 粒子分散用凝胶、粒子分散凝胶、粒子分散用凝胶的制造方法和粒子分散凝胶的制造方法
WO2014198422A1 (de) Transdermales therapiesystem (tts) mit rotigotin

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210121

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210121

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220127

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220426

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220623

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220727

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220727

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221201

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230501

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230501

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230823

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230920

R150 Certificate of patent or registration of utility model

Ref document number: 7353980

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150